Glucocorticoid regulation of SLIT/ROBO tumour suppressor genes in the ovarian surface epithelium and ovarian cancer cells

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Dickinson, Rachel E ^a   Fegan, K Scott ^a   Ren, Xia ^a   Hillier, Stephen G ^a   Duncan, W Colin ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; SMALL INTERFERING RNA; HYDROCORTISONE; IMMUNOGLOBULIN RECEPTOR; NERVE PROTEIN; ROUNDABOUT RECEPTOR; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MENSTRUAL CYCLE; OVARY CANCER; ROBO GENE; ROBO1 GENE; ROBO2 GENE; ROBO4 GENE; SLIT GENE; SLIT2 GENE; SLIT3 GENE; TUMOR SUPPRESSOR GENE; DRUG EFFECT; EPITHELIUM; FEMALE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NEOPLASM; OVARIAN EPITHELIAL CANCER; OVARY TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR GENE;

MAMMALIA;

APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; EPITHELIUM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; NEOPLASMS, GLANDULAR AND EPITHELIAL; NERVE TISSUE PROTEINS; OVARIAN NEOPLASMS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 81755166537     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027792     Document Type: Article

References (47)

1. Kidd T, Bland KS, Goodman CS, (1999) Slit is the midline repellent for the robo receptor in Drosophila. Cell 96: 785-794.
2. Seeger M, Tear G, Ferres-Marco D, Goodman CS, (1993) Mutations affecting growth cone guidance in Drosophila: genes necessary for guidance toward or away from the midline. Neuron 10: 409-426.
3. Brose K, Bland KS, Wang KH, Arnott D, Henzel W, et al. (1999) Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 96: 795-806.
4. Strickland P, Shin GC, Plump A, Tessier-Lavigne M, Hinck L, (2006) Slit2 and netrin 1 act synergistically as adhesive cues to generate tubular bi-layers during ductal morphogenesis. Development 133: 823-832.
5. Dickinson RE, Hryhorskyj L, Tremewan H, Hogg K, Thomson AA, et al. (2010) Involvement of the SLIT/ROBO pathway in follicle development in the fetal ovary. Reproduction 139: 395-407.
6. Dickinson RE, Duncan WC, (2010) The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system. Reproduction 139: 697-704.
7. Hinck L, (2004) The versatile roles of "axon guidance" cues in tissue morphogenesis. Dev Cell 7: 783-793.
8. Chedotal A, Kerjan G, Moreau-Fauvarque C, (2005) The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ 12: 1044-1056.
9. Dallol A, Dickinson RE, Latif F, (2005) Epigenetic disruption of the SLIT-ROBO interactions in human cancer. In: Esteller M, editors. DNA Methylation, Epigenetics and Metastasis pp. 191-214 Springer Netherlands.
10. Latil A, Chene L, Cochant-Priollet B, Mangin P, Fournier G, et al. (2003) Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int J Cancer 103: 306-315.
11. Narayan G, Goparaju C, Arias-Pulido H, Kaufmann AM, Schneider A, et al. (2006) Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer 5: 16.
12. Singh RK, Indra D, Mitra S, Mondal RK, Basu PS, et al. (2007) Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene. Hum Genet 122: 71-81.
13. Yu J, Cao Q, Wu L, Dallol A, Li J, et al. (2010) The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. Oncogene 29: 5370-5380.
14. Dallol A, Morton D, Maher ER, Latif F, (2003) SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 63: 1054-1058.
15. Jin J, You H, Yu B, Deng Y, Tang N, et al. (2009) Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas. Biochem Biophys Res Commun 379: 86-91.
16. Kim HK, Zhang H, Li H, Wu TT, Swisher S, et al. (2008) Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma. Neoplasia 10: 1411-1420.
17. Marlow R, Strickland P, Lee JS, Wu X, Pebenito M, et al. (2008) SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res 68: 7819-7827.
18. Prasad A, Fernandis AZ, Rao Y, Ganju RK, (2004) Slit protein-mediated inhibition of CXCR4-induced chemotactic and chemoinvasive signaling pathways in breast cancer cells. J Biol Chem 279: 9115-9124.
19. Stella MC, Trusolino L, Comoglio PM, (2009) The Slit/Robo system suppresses hepatocyte growth factor-dependent invasion and morphogenesis. Mol Biol Cell 20: 642-657.
20. Liao WX, Wing DA, Geng JG, Chen DB, (2010) Perspectives of SLIT/ROBO signaling in placental angiogenesis. Histol Histopathol 25: 1181-1190.
21. Duncan WC, McDonald SE, Dickinson RE, Shaw JL, Lourenco PC, et al. (2010) Expression of the repulsive SLIT/ROBO pathway in the human endometrium and Fallopian tube. Mol Hum Reprod 16: 950-959.
22. Dickinson RE, Myers M, Duncan WC, (2008) Novel Regulated Expression of the SLIT/ROBO Pathway in the Ovary: Possible Role during Luteolysis in Women. Endocrinology 149: 5024-5034.
23. Duncan WC, Myers M, Dickinson RE, van den Driesche S, Fraser HM, (2009) Luteal development and luteolysis in the primate corpus luteum. Animal Reprod 6: 34-46.
24. Myers M, Lamont MC, van den Driesche S, Mary N, Thong KJ, et al. (2007) Role of luteal glucocorticoid metabolism during maternal recognition of pregnancy in women. Endocrinology 148: 5769-5779.
25. Leung PC, Choi JH, (2007) Endocrine signaling in ovarian surface epithelium and cancer. Hum Reprod Update 13: 143-162.
26. Purdie DM, Bain CJ, Siskind V, Webb PM, Green AC, (2003) Ovulation and risk of epithelial ovarian cancer. Int J Cancer 104: 228-232.
27. Argento M, Hoffman P, Gauchez AS, (2008) Ovarian cancer detection and treatment: current situation and future prospects. Anticancer Res 28: 3135-3138.
28. Hillier SG, Tetsuka M, (1998) An anti-inflammatory role for glucocorticoids in the ovaries? J Reprod Immunol 39: 21-27.
29. Gubbay O, Guo W, Rae MT, Niven D, Langdon SP, et al. (2005) Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas. Br J Cancer 92: 1927-1933.
30. Rae MT, Niven D, Critchley HO, Harlow CR, Hillier SG, (2004) Anti-inflammatory steroid action in human ovarian surface epithelial cells. J Clin Endocrinol Metab 89: 4538-4544.
31. Rae MT, Price D, Harlow CR, Critchley HO, Hillier SG, (2009) Glucocorticoid receptor-mediated regulation of MMP9 gene expression in human ovarian surface epithelial cells. Fertil Steril 92: 703-8.
32. Avci ME, Konu O, Yagci T, (2008) Quantification of SLIT-ROBO transcripts in hepatocellular carcinoma reveals two groups of genes with coordinate expression. BMC Cancer 8: 392.
33. Dallol A, Da Silva NF, Viacava P, Minna JD, Bieche I, et al. (2002) SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 62: 5874-5880.
34. Mertsch S, Schmitz N, Jeibmann A, Geng JG, Paulus W, et al. (2008) Slit2 involvement in glioma cell migration is mediated by Robo1 receptor. J Neurooncol 87: 1-7.
35. Ma S, Liu X, Geng JG, Guo SW, (2010) Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma. Am J Obstet Gynecol 202: 68.e1-68.e11.
36. Papacleovoulou G, Hogg K, Fegan KS, Critchley HO, Hillier SG, et al. (2009) Regulation of 3beta-hydroxysteroid dehydrogenase type 1 and type 2 gene expression and function in the human ovarian surface epithelium by cytokines. Mol Hum Reprod 15: 379-92.
37. Morrissey C, Dallol A, Latif F, Gazdar A, Minna JD, (2004) The candidate tumour suppressor gene SLIT-2 supresses growth and induces apoptosis in lung and breast cancer. Proc Amer Assoc Cancer Res 45: Abstract 3519.
38. Gascoyne DM, Kypta RM, Vivanco MM, (2003) Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL. J Biol Chem 278: 18022-18029.
39. Runnebaum IB, Bruning A, (2005) Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2. Clin Cancer Res 11: 6325-6332.
40. Sui M, Chen F, Chen Z, Fan W, (2006) Glucocorticoids interfere with therapeutic efficacy of paclitaxel agianst human breast and ovarian xenograft tumors. Int J Cancer 119: 712-717.
41. Zhang C, Beckerman B, Kallifatidis G, Liu Z, Rittgen W, et al. (2006) Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma. Int J Oncol 29: 1295-1301.
42. Zhang C, Mattern J, Haferkamp A, Pfitzenmaier J, Hohenfellber M, et al. (2006) Corticosteroid-induced chemotherapy resistance in urological cancers. Cancer Biol Ther 5: 59-64.
43. El Etreby MF, Liang Y, Lewis RW, (2000) Induction of apoptosis by mifeprostone and tamoxifen in human LNCaP prostate cancer cells in culture. Prostate 43: 31-42.
44. Goyeneche AA, Caron RW, Telleria CM, (2007) Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo. Clin Cancer Res 13: 3370-3379.
45. Sengupta S, Vonesch JL, Walzinger C, Zheng H, Wasylyk B, (2000) Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells. EMBO J 19: 6051-6064.
46. Chebotaev D, Yemelyanov A, Budunova I, (2007) The mechanism of tumor suppressor effect of glucocorticoid receptor in skin. Mol Carcinog 46: 732-740.
47. van den Driesche S, Smith VM, Myers M, Duncan WC, (2008) Expression and regulation of oestrogen receptors in the human corpus luteum. Reproduction 135: 509-17.